Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Primary Health Care Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

06 Feb 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Primary Health Care Ltd (PRY-AU)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

12 Feb 2016 Thomson Reuters Stock Report 11 $25.00

Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review

Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review Summary Primary Health Care Limited (PHC) is a h...

04 Feb 2016 GlobalData 41 $300.00

Wright Investors Service Comprehensive Report for Primary Healthcare Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

10 Dec 2015 Wright Reports 55 $75.00

Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review

Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review Summary Primary Health Care Limited (PHC) is a h...

04 Dec 2015 GlobalData 47 $300.00

Is Primary Health Care Limited Worth a Higher Bid?

18 Nov 2015 Sadif Analytics Prime 12 $25.00

Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review

Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review Summary Primary Health Care Limited (PHC) is a h...

04 Sep 2015 GlobalData 44 $125.00

Is Primary Health Care Limited Worth its Desired Premium?

17 Aug 2015 Sadif Analytics Prime 12 $25.00

PRY.AX - Event Transcript of Primary Health Care Ltd conference call, Aug. 11, 2015 / 7:30PM ET

Edited Event Transcript of PRY.AX conference call, Aug. 11, 2015 / 7:30PM ET Sydney, Aug 11, 2015 (Thomson StreetEvents...

11 Aug 2015 Thomson Reuters StreetEvents 25 $75.00

Play the Gap to Profit from Australia's Undervalued Biotech Gems: John Hester of Bell Potter Securities

Investors who lament missing the U.S. biotech bull market might have another avenue to pursue. Biotech valuations in Australi...

22 Jul 2015 Streetwise Reports 7 $69.00